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Abstract: Background: Blackcurrant is rich in anthocyanins that may protect against exercise-induced
muscle damage (EIMD) and facilitate a faster recovery of muscle function. We examined the effects
of New Zealand blackcurrant (NZBC) extract on indices of muscle damage and recovery following a
bout of strenuous isokinetic resistance exercise. Methods: Using a double-blind, randomised, placebo
controlled, parallel design, twenty-seven healthy participants received either a 3 g·day−1 NZBC
extract (n = 14) or the placebo (PLA) (n = 13) for 8 days prior to and 4 days following 60 strenuous
concentric and eccentric contractions of the biceps brachii muscle on an isokinetic dynamometer.
Muscle soreness (using a visual analogue scale), maximal voluntary contraction (MVC), range of
motion (ROM) and blood creatine kinase (CK) were assessed before (0 h) and after (24, 48, 72 and
96 h) exercise. Results: Consumption of NZBC extract resulted in faster recovery of baseline MVC
(p = 0.04), attenuated muscle soreness at 24 h (NZBC: 21 ± 10 mm vs. PLA: 40 ± 23 mm, p = 0.02)
and 48 h (NZBC: 22 ± 17 vs. PLA: 44 ± 26 mm, p = 0.03) and serum CK concentration at 96 h (NZBC:
635 ± 921 UL vs. PLA: 4021 ± 4319 UL, p = 0.04) following EIMD. Conclusions: Consumption of
NZBC extract prior to and following a bout of eccentric exercise attenuates muscle damage and
improves functional recovery. These findings are of practical importance in recreationally active and
potentially athletic populations, who may benefit from accelerated recovery following EIMD.
Keywords: exercise-induced muscle damage; recovery; oxidative stress; anthocyanin; New Zealand
blackcurrant
1. Introduction
Strenuous eccentric exercise is known to induce skeletal muscle damage, with pro-
longed (2–5 days) effects, including reduced muscle strength and range of motion (ROM),
increased muscle soreness and swelling, and the leakage of myocellular proteins (e.g., crea-
tine kinase [CK]) into the circulation [1]. Whilst there is evidence to support a potential
role for exercise induced muscle damage (EIMD) in the hypertrophic response, a threshold
exists, beyond which damage may interfere with the muscle remodeling process [2]. Given
that a high degree of EIMD causes pain and impaired muscle function [1,3], excessive dam-
age can reduce an individual’s capacity to train on successive days, dampen the training
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stimulus and impede adaptation. Furthermore, adverse effects tend to be exacerbated
when the exercise is unaccustomed, which could discourage untrained individuals from
further participation in exercise activities, preventing repeat exposure and positive training
adaptations [4].
The initial phase of EIMD involves structural disruption of the sarcomeres due to
mechanical strain, followed by disturbed excitation–contraction coupling and calcium
signalling and a proinflammatory response [1]. Leukocyte accumulation contributes to the
degradation of damaged muscle tissue through phagocytosis and by releasing proteolytic
enzymes and reactive oxygen (ROS) and nitrogen species (RNS) [3]. If left unabated, such
derivatives can exceed the antioxidant defense capacity and induce a secondary cascade of
muscle fibre disruption, thereby hindering the recovery process [3].
Since inflammation and ROS/RNS derivatives are involved in EIMD, there has been
considerable interest in the efficacy of dietary foods/supplements with suggested anti-
inflammatory and antioxidant effects to ameliorate EIMD. Plant-derived polyphenolic
compounds, such as anthocyanins, show a high endogenous antioxidant capacity [5] and
support innate immune defenses [6,7]. Studies that have explored the effects of polyphe-
nolic supplements and rich food/drink sources, such as quercetin [8,9], beetroot [10],
blueberry [11], cherry [12–14] and pomegranate juice [15,16] have shown equivocal re-
sults on recovery from EIMD. The majority find no difference in CK response after
exercise [9–13,16], suggesting an inability to protect fibres from secondary muscle damage.
This conflicting evidence may be in part attributed to differences in study design. Some
have used the contralateral limb to mitigate the repeated bout effect [9,11–14] but carryover
to the non-exercising limb may confound results [17,18], and therefore a between-subject
research design is preferable. Variation in mode, intensity and duration of exercise to
elicit muscle damage is also apparent. EIMD is greater and/or recovery is slower fol-
lowing single joint upper body exercise [19,20], when contractions are performed at high
intensity [21] and at a long muscle length [22]. Finally, the type, dose and duration of
polyphenolic supplementation is likely to influence the efficacy of the recovery intervention.
Supplementing before exercise may effectively prime the cell (up-regulating antioxidant
capacity) to cope with the initial increase in ROS, while continued supplementation in the
recovery period may attenuate ROS induced secondary damage [23]. Blackcurrants possess
a high inherent antioxidant capacity compared to most other fruits, which is attributed
to their high anthocyanin and vitamin C content [24,25]. Consumption of anthocyanin-
rich New Zealand blackcurrants (NZBC) extract exerts positive physiological effects on
the cardiovascular [26–28], metabolic [29] and immune systems [30,31], but few studies
have examined their capacity to attenuate traditional symptoms of EIMD (e.g., strength,
soreness, ROM, CK concentration) [23]. Given the close relationship between plasma
anthocyanin bioavailability and functional efficacy, it may be beneficial to perform exer-
cise 1–2 h after the consumption of supplements/foods, to coincide with peak plasma
anthocyanin levels [32–34], in an attempt to maximize adaptive cellular events and facili-
tate recovery. Indeed, recent studies have found acute consumption of NZBC extract 1 h
prior to exercise facilitates recovery from exercise-induced oxidative stress and preserves
circulating neutrophil function [35], and when consumed daily, promotes a protective
antioxidant/anti-inflammatory cellular environment that supports positive adaptative
processes [36].
The purpose of this study was to investigate the effects of NZBC extract on indices of
muscle damage and recovery following a bout of strenuous isokinetic resistance exercise.
We hypothesized that given its high anthocyanin content, NZBC would protect against
exercise-induced inflammation and oxidative stress, reducing the extent of secondary
muscle damage and facilitate a faster recovery of muscle function.
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2. Materials and Methods
2.1. Participants
Twenty-seven healthy and non-resistance trained males and females volunteered to
participate in the study. Participants were recruited from student and staff cohorts at the
University of Surrey by word of mouth, email and social media displays. Participants were
included if they were aged between 18–45 years, had a healthy BMI (19–29.9 kg/m2) and
did not meet physical activity guidelines for resistance exercise frequency (<2 sessions
per week). Participants were excluded if they (i) smoked, (ii) took medication (excluding
contraception), (iii) had a BMI ≥ 30 kg/m2, (iv) had hypertension, (v) had a history of
musculoskeletal upper limb injuries, (vi) performed resistance exercise more than twice
per week and/or (vii) used dietary supplements that could influence muscle recovery
or function (i.e., protein supplements, antioxidants). All participants completed a pre-
participation health questionnaire, and were informed of the purpose, risks and discomforts
associated with the investigation before giving written and informed consent. The study
was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by Surrey University Research Ethics Committee (UEC/2015/112/FHMS) prior
to the first participant enrolment (10 June 2016) and was retrospectively registered on the
ClinicalTrials.gov (NCT05010057) database (17 August 2021). Participant characteristics
and descriptive statistics are listed in Table 1.
Table 1. Participant characteristics and descriptive statistics between the NZBC (n = 14) and PLA
groups (n = 13).
NZBC Placebo p Value
Gender 10 women, 4 men 9 women, 4 men
Age (yrs) 24 ± 2 23 ± 2 0.272
Stature (cm) 170 ± 9 164 ± 11 0.175
Body Mass (kg) 67.9 ± 15.7 59.0 ± 7.9 0.120 *
BMI (kg/m2) 23.4 ± 3.5 21.8 ± 2.3 0.204
Baseline MVC (Nm) 42.2 ± 18.3 35.8 ± 13.9 0.299
Baseline CK (UL) 118 ± 80 155 ± 99 0.487
Values are means ± SD. p value denotes Independent T-test or * Mann-Whitney U outcome. NZBC, New Zealand
Blackcurrant; PLA, Placebo; MVC, maximal voluntary contraction; CK, creatine kinase.
2.2. Study Design
The study used a double-blind, randomised, placebo-controlled, parallel design to
investigate the effects of NZBC extract on indices of muscle damage and recovery following
a bout of strenuous isokinetic resistance exercise. Using a sealed envelope randomised
block procedure, familiarised participants received either the NZBC extract (n = 14) or the
placebo (PLA) (n = 13) for 12 days. On day 8, participants performed maximal concentric
and eccentric contractions of the biceps brachii muscle group on an isokinetic dynamometer
(CSMi Humac Norm, Massachusetts). Muscle soreness (using a visual analog scale), muscle
function (via measures of maximal voluntary contraction [MVC]), ROM and serum CK
were assessed before (0 h) and after (24, 48, 72 and 96 h) exercise.
Criterion measures were performed on days 8–12 at a similar time in the morning
(between 7–10 am ± 1 h) after a 10 h overnight fast. Participants were asked to avoid taking
non-steroidal anti-inflammatory drugs (NSAIDs) for the duration of the study period and
abstain from exercise and alcohol consumption between days 7 and 12. A 6-day food diary
was started 24 h prior to the muscle damage exercise bout and continued for 96 h (day
7–12). This was analysed using Nutritics software to determine macronutrient distribution
and total energy intake during the study period. In addition, daily anthocyanin intake was
estimated using the Phenol-Explorer database [37]. A physical activity diary was used to
check compliance with instructions to avoid exercise.
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2.3. Preliminary Measures and Familarisation Session
Participants attended a preliminary visit 2–3 weeks prior to experimental trials to
determine anthropometric measures, establish settings on the isokinetic dynamometer
(Cybex NORM®, Humac, CA, USA) and practice the protocols for assessing strength (MVC)
and inducing muscle damage. Stature and body mass were measured using a portable
stadiometer (Seca 213, Seca GmbH, Hamburg, Germany) and digital column scales (Seca
799, Seca GmbH, Hamburg, Germany), respectively. The isokinetic dynamometer was
set up according to manufacture guidelines for elbow flexion, with the dynamometer
orientated at 0◦ tilt, 5◦ rotation and position 4 for height. The position of the seat was
adjusted for each individual to align the lateral epicondyle with the dynamometer axis
of rotation. This set-up was recorded and replicated on subsequent visits. Participants
practiced MVCs in accordance with the protocol below and completed ten repetitions of
the muscle damage protocol to confirm they were comfortable with the range of motion
(5◦ to 135◦ of elbow flexion). The latter was performed at submaximal intensity (RPE 5,
Borg CR10 scale) to avoid repeated bout effect.
2.4. Supplement Dosing (Day 1–12)
Familiarised participants received twelve NZBC extract (300 mg active cassis contain-
ing 105 mg of anthocyanins, i.e., 35–50% delphinidin-3-rutinoside, 5–20% delphinidin-3-
glucoside, 30–45% cyanidin-3-rutinoside, 3–10% cyanidin-3-glucoside) (Health Currancy
Ltd. [Camberley, UK]/CurraNZ Ltd. [Auckland, New Zealand]) or placebo (300 mg
microcrystalline cellulose M102) capsules, and were instructed to consume one capsule
every morning. On day 8, participants were instructed to consume their supplement 1 h
before performing the muscle damage exercise protocol.
2.5. Muscle Damage Exercise Protocol (Day 8)
Following a warm-up and measures of MVC on the isokinetic dynamometer (see
description below) the participants performed 4 × 15 repetitions of maximal concentric and
eccentric contractions of the biceps brachii muscle group in the dominant arm. Participants
were given a 1-min recovery period between sets. The angular velocity was set at 45◦/s
for concentric actions and 60◦/s for eccentric actions. The ROM was standardized from 5◦
to 135◦ of elbow flexion. Participants were instructed to perform the repetitions ‘as hard
as they can’ and investigators gave verbal encouragement throughout. Additional MVC
assessments were performed immediately post-exercise (0 h) to provide insight into the
fatiguability of the exercise protocol.
2.6. Criterion Measures (Days 8–12)
Criterion measures were performed before muscle damage exercise on day 8, and at
the same time on days 9, 10, 11 and 12 within a ± 1 h window, reflecting 24, 48, 72 and 96 h
post-exercise timepoints.
Elbow flexor muscle soreness was measured using a visual analogue scale (VAS).
Participants were asked to extend their dominant arm and rate their perceived pain on
the horizontal scale, from ‘no soreness’ (0 mm) on the left anchor point to ‘extremely sore’
(100 mm) on the right. Pain was identified by measuring the distance from the left anchor
point (0 mm).
Elbow range of motion (ROM) was determined using a two-arm goniometer. The
goniometer axis was placed over the lateral epicondyle, and the stationary and moving
arm were aligned with the humerus (centre of acromion process) and radius (centre of
styloid process), respectively. Participants were asked to maximally flex the elbow joint
and then relax their arm until the point of discomfort, whilst ensuring their upper arm
stayed vertical and in contact with the side of their body. The joint angle at maximal flexion
and extension was measured 3 times, and total ROM was calculated before being averaged.
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Participants’ mid-upper arm circumference (MAC) was measured at the midpoint
of the distance from the acromion process (acromiale) to the olecranon process (radiale).
Three measures were made and the average recorded.
For serum creatine kinase, 4 mL blood samples were obtained from the antecubital
vein prior to eccentric exercise (day 8) and at 24, 48, 72 and 96 h post-exercise (day 9, 10,
11 and 12). Samples were centrifuged for 10 min at 1000× g at 4 ◦C. Analysis of serum
CK concentrations was conducted by an external pathology lab (Berkshire and Surrey
Pathology Services) and performed with CK assay kits using the ADVIA® 1800 Clinical
Chemistry System (Siemens Healthcare Ltd, Camberley, UK).
For muscle function, participants performed a warm-up involving low load resistance
exercise (1 × 20 reps of single arm bicep curl at ~5 RPE (Borg CR10 scale) and a stretching
routine of the major muscle groups (latissimus dorsi, pectorals, rhomboids, deltoids,
biceps, triceps, wrist flexor and extensor) of the upper extremity. They then lay on the
isokinetic dynamometer with their dominant arm secured at their side in 90◦ elbow flexion.
Participants performed 3 submaximal isometric contractions as a warm-up, followed by 3
maximal efforts held for 5 s interspaced with 60 s recovery. Isometric MVC was determined
from the highest peak torque (N-m) from the best trial (out of 3).
2.7. Statistical Analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences
(SPSS 24, IBM, Armonk, NY, USA). Shapiro–Wilks tests were utilized to test the data for
normality, and when this assumption was violated, log-transformations were attempted.
Levene’s tests were used to verify homogeneity of variance and Mauchly’s tests to assess
sphericity. When the sphericity assumption was violated, Greenhouse–Geisser corrections
were performed. Independent sample t-tests were performed to determine if there were
significant differences between groups at baseline. Repeated measures ANOVAs were
performed for mid-arm circumference, ROM and MVC. Friedman and Mann–Whitney
U tests were used to analyze perceived soreness and CK results. For soreness, post-hoc
analysis with Wilcoxon signed-rank tests was conducted with a Bonferroni correction to




The characteristics of participants in the NZBC and PLA group are displayed in Table 1.
There were no differences in baseline variables between groups. All participants completed
daily supplement logs and reported consumption of their capsules in the morning as
instructed, suggesting 100% compliance. Analysis of the food diaries confirmed there
was no difference in total energy intake, consumption of macronutrients and anthocyanin
between groups (Table 2).
Table 2. Dietary analysis for NZBC (n = 14) and PLA groups (n = 13).
NZBC Placebo p Value
Energy (kcal day−1) 1880 ± 905 1617 ± 408 1.000 *
Carbohydrate (g day−1) 221 ± 110 182 ± 53 0.305
Protein (g day−1) 78 ± 22 69 ± 22 0.484
Fat (g day−1) 68 ± 25 74 ± 46 0.784
Anthocyanin (mg day−1) 24 ± 28 38 ± 33 0.279 *
Values are means ± SD. p value denotes Independent t-test or * Mann–Whitney U outcome.
3.2. Muscle Function
Figure 1 displays the change in MVC following the muscle damage protocol (2-way
ANOVA main effect for time, p < 0.001). Post-hoc Bonferroni analysis confirmed MVC
was significantly lower immediately, 24 h, 48 h and 72 h post-exercise (p < 0.05) but
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participants had regained their baseline strength by 96 h post-exercise (p = 0.251). There
was no group (2-way ANOVA main effect for group, p = 0.399) or interaction effect (2-way
ANOVA group * time, p = 0.162) for MVC. However, in the NZBC group, only transient
reductions in MVC were observed immediately following the eccentric exercise (mean
difference; 15.5 ± 9.8 Nm, p = 0.001) with no difference in strength measures at 24 h
(6.7 ± 8.3 Nm, p = 0.245) 48 h (5.9 ± 9.3 Nm, p = 0.538), 72 h (5.6 ± 8.0 Nm, p = 0.554) and
96 h (3.5 ± 10.1 Nm, p = 0.898) post-exercise vs. baseline (1-way ANOVA with post-hoc
Bonferroni analysis, p < 0.05). When post-exercise MVC was expressed relative to baseline
(%), an interaction effect was observed (2-way ANOVA group * time, p = 0.035).
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Figure 1. Change in maximal voluntary contraction of the elbow flexor muscles following eccentric
exercise (percentage of pre-exercise strength) in the PLA and NZBC groups. Values are means ± SEM.
3.3. Creatine Kinase
Figure 2 displays the changes in serum CK concentration over the course of the exper-
imental period. CK significantly increased after the muscle damage protocol in the PLA
group (Fri dman Test, p = 0.008) but remained unchanged in the NZBC group (Friedman
Test, p = 0.798). Post-hoc Wilcoxo signed rank analysis with Bonferroni correction con-
firmed CK was significantly elevated above baseline in the PLA group at 96 h post-exercise
(p = 0.003). Furthermore, serum CK levels in the NZBC group displayed a trend toward
being lower at 72 h (Mann-Whitney U test, NZBC: 542 ± 818 UL vs. PLA: 3977 ± 5392 UL,
p = 0.080) and were significantly lower at 96 h post-exercise (Mann–Whitney U test, NZBC:
635 ± 921 UL vs. PLA: 4021 ± 4319 UL, p = 0.040).
.4. Muscle Soreness
Participants in both groups reported a significant change in muscle soreness over time
(Friedman Tests, p < 0.001, Figure 3). An increase in muscle soreness was observed 24 h
after the muscle damage protocol, peaking at 48 h and decreasing thereafter (Post-hoc
Wilcoxon signed rank analysis with Bonferroni correction, p < 0.01). A Mann–Whitney
U test confirmed participants in the NZBC group experienced reduced muscle soreness
compared to the PLA group at 24 h (NZBC: 21 ± 10 mm vs. PLA: 40 ± 23 mm, p = 0.018)
and 48 h (NZBC: 22 ± 17 vs. PLA: 44 ± 26 mm, p = 0.025) post-exercise.
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Figure 3. Muscle soreness before and after eccentric exercise in the PLA and NZBC groups. Values
are means ± SEM, * significant difference between groups (p < 0.05).
3.5. Range of Motion
Participants in both groups experienced a significant change in their elbow ROM
over time (Friedman Tests, p < 0.01). A decrease in elbow ROM was evident from 24 h
post-exercise (Post-hoc Wilcoxon signed rank analysis with Bonferroni correction, p < 0.001).
At 96 h post-exercise, ROM had recovered in the NZBC group but remained suppressed in
the PLA group compared to baseline (Table 3). However, there was no difference between
groups at any time point (Mann–Whitney U tests, p > 0.05, Table 3).
Table 3. Elbow range of motion (ROM) and mid arm circumference (MAC) in NZBC and Placebo
groups before and after muscle damage protocol.
Variable Group 0 h 24 h 48 h 72 h 96 h
ROM (◦)
NZBC 150 ± 21 139 ± 34 * 139 ± 31 * 140 ± 25 * 142 ± 26
PLA 147 ± 20 134 ± 26 * 134 ± 26 * 136 ± 22 * 136 ± 20 *
MAC (cm)
NZBC 28.6 ± 4.2 29.0 ± 4.2 29.1 ± 4.2 28.6 ± 4.3 28.6 ± 4.1
PLA 27.9 ± 2.9 28.0 ± 2.9 28.3 ± 2.7 28.6 ± 2.6 28.6 ± 2.4
ROM, range of motion; MAC, mid-arm circumference; NZBC, New Zealand Blackcurrant; PLA, Placebo. Post-hoc
Wilcoxon signed rank analysis with Bonferroni correction * significantly different to pre-exercise (0 h) (p < 0.05).
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3.6. Mid-Arm Circumference
MAC significantly changed in response to the muscle damage protocol (2-way ANOVA
main effect for time, p = 0.026, Table 3). Post-hoc analysis with Bonferroni correction
showed MAC increased from baseline at 48 h post-exercise (post-hoc t-test with Bonferroni
correction, p = 0.01). There was no group (2-way ANOVA main effect for group, p = 0.856)
or interaction effect (2-way ANOVA group * time, p = 0.116).
4. Discussion
The purpose of this study was to investigate the effects of NZBC extract on indices of
muscle damage and recovery following a bout of strenuous isokinetic resistance exercise.
This is the first study to observe that 12-day intake of NZBC extract by non-resistance
trained individuals results in faster recovery of muscle function (maximal isometric torque),
attenuated muscle soreness (at 24–48 h) and serum CK concentration (at 96 h) following
EIMD. Our results suggest consumption of NZBC extract prior to and following a bout of
eccentric exercise attenuates muscle damage and improves functional recovery. These find-
ings are of practical importance in recreationally active and potentially athletic populations,
who may benefit from accelerated recovery following EIMD.
Muscle fibre disruption occurs following strenuous exercise, especially if the partic-
ipant is unaccustomed to the activity, and it involves eccentric muscle contractions. It is
commonly characterized by a decrease in muscular strength and ROM, localised inflam-
mation and muscle soreness, and elevated levels of intramuscular proteins (e.g., CK). in
the blood. We observed such changes in criterion measures in both participant groups,
which suggests our isokinetic resistance exercise protocol evoked a degree of muscle fibre
disruption. However, in support of our hypothesis, we found that consumption of NZBC
extract was able to protect the skeletal muscle and reduced the extent of EIMD.
A reduction in maximal isometric torque is regarded as the most valid indicator of
EIMD [38]. Muscle strength decreased by ~29% immediately after exercise and was restored
within 96 h, in agreement with previous studies implementing a similar eccentric elbow
flexor exercise protocol [15]. Although the magnitude of the decrease in MVC was the
same between groups, the rate of MVC recovery was accelerated in the NZBC group. This
may reflect a reduced magnitude of muscle damage as described by Chen et al. [39]. The
initial damage and strength loss following lengthening muscle actions is thought to occur
because of both mechanical strain and oxidative stress [40]. Consumption of blackcurrant
anthocyanins may alleviate oxidative stress and facilitate recovery [30]. Indeed, a recent
study has shown consumption of blackcurrant anthocyanin-rich extract (BAE) 1 h prior to
exercise can reduce plasma protein carbonyl levels and plasma oxidative capacity at 2 and
6 h post-exercise compared to the placebo group [35]. Authors speculated that the increase
in plasma anthocyanins as a result of BAE consumption, activated cellular redox-sensitive
signaling pathways (e.g., Nrf2/ARE transcription), causing the up-regulation of cellular
antioxidant systems and subsequently lowering oxidative stress indices during exercise
recovery. Although in the present study we did not perform mechanistic experiments
it seems plausible that the consumption of NZBC extract increased cellular antioxidant
defense capacity, thus reducing initial muscle damage and promoting tissue repair.
Primary muscle damage initiates a cellular repair signaling pathway. Neutrophils and
monocytes migrate to the damaged tissue, and their accumulation promotes the degra-
dation of cellular debris through phagocytosis and the release of ROS and RNS [1]. The
problem arises when the degradation is not exclusive to cellular debris, but also affects
previously uninjured muscle. This is considered the second phase of EIMD and leads to
delayed onset of muscle soreness (DOMS) and increased CK release. DOMS peaked in
our participants at 48 h, with pain persisting until 72 h, which is consistent with previous
observations [1]. Participants who consumed NZBC extract reported less pain with active
elbow extension than subjects who consumed the placebo. Muscle tenderness is thought
to occur as a result of oedema. Specifically, disruptions to the extracellular matrix (ECM)
cause an increase in interstitial inflammatory mediators, which interact with nociceptors
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in the muscle to trigger the pain response [41]. The consumption of BAE has been previ-
ously shown to have anti-inflammatory effects [30], although the underlying mechanism
is unknown. Improvements in blood flow as a result of BAE consumption may support
rapid neutrophil influx and outflux. Furthermore, BAE consumption is found to enhance
neutrophil antioxidant capacity and preserve functionality against exercise-induced oxida-
tive stress [35]. By collectively improving blood flow and preserving neutrophil function
(minimizing dysregulation (e.g., delated apoptosis)), it may reduce the accumulation of
neutrophils, the release of their cytotoxic products and further local tissue damage. NZBC
consumption may therefore have attenuated further disruption to the ECM, reduced inflam-
mation (and oedema) and the nociceptor response. Whilst we observed an increase in MAC
following exercise indicating swelling, there was no difference between groups. It is likely
that circumference measurements are not sensitive enough to assess oedema particularly
when related to micro-rather than macro-trauma. Furthermore, localized swelling may
have been more prominent at other points/lengths of the muscle and not captured by this
mid-arm measure. In line with similar levels of oedema, we observed no difference in
relaxed elbow ROM between groups, indicating a comparable level of muscle and/or joint
stiffness, as observed previously in tart cherry studies [13,14,16].
We observed a significant elevation in serum CK post-exercise in the placebo group.
This response is similar to that reported in previous studies utilising a similar exercise
protocol (eccentric elbow flexion) in non-resistant trained population [9,42]. We noted
a large inter-individual variation in the CK response to the muscle damage protocol
in the placebo group. Whilst this is consistent with the literature [43], it is interesting
that the variability between individuals is significantly smaller in the NZBC group. We
speculate that this is due to the free radical scavenging activity and reducing power of
black currant extract [44]. Indeed, CK levels were significantly reduced in the NZBC
group at 96 h post-exercise suggesting attenuation of secondary muscle damage caused by
inflammatory amplifiers and ROS/RNS. This is in contrast to other studies investigating
different antioxidant-rich foods/supplements that found no reduction in circulating CK
levels relative to controls/placebos [11,12,45]. By supplementing with NZBC before (8
days) and in the days following (4 days) strenuous exercise, we may have increased
anthocyanins bioavailability and effectively primed the cell (up-regulating antioxidant
capacity) to neutralize the initial (exercise-induced) and continued release of ROS (in
damaged myofibres), and attenuated further disruption of the sarcolemma by oxidative
reactions and additional leakage of CK [23]. Similarly, consumption of black currant nectar
(BCN) reduced CK levels at 48 and 96 h post eccentric knee extension exercise (3 × 10 sets
@ 115% of IRM) [23]. This was preceded by a reduced elevation in IL-6 at 24 h post-exercise
in the BCN vs. placebo group, indicating a dampened inflammatory response.
The inflammatory response to myodamage can have either a beneficial (i.e., contribute
to growth processes) or detrimental (i.e., exacerbate the initial mechanical damage) effect
on muscle function depending on the magnitude of the response [2,46]. Excessive or inap-
propriate timing of supplements (e.g., antioxidant, anti-inflammatory) that significantly
dampen oxidative stress during exercise may prevent adaptive events and be detrimental
to the recovery process [47]. The impact of prolonged daily NZBC extract consumption on
the hypertrophic response to resistance training is not known. Early indications appear
positive; daily consumption of BAE for 5 weeks promotes antioxidant/anti-inflammatory
cellular events that facilitate exercise recovery [36] but the influence on training adaptations
are yet to be examined.
This is the first study to investigate whether NZBC extract consumption can attenuate
traditional symptoms of resistance based EIMD. The strengths of this study include the
use of an isokinetic dynamometer to better control the stimulus for muscle damage and
the adoption of a double-blind placebo-controlled, parallel design, which is preferable to
avoid the repeated bout effect. However, this study also has several limitations that must
be considered when interpreting the findings. We only assessed indirect markers of muscle
damage and it would have been valuable to determine if histological and/or biochemical
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differences were observed. We did not measure systemic markers of inflammation (IL-6,
TNF-a, IL-8) as these do not adequately reflect the inflammatory response to eccentric exer-
cise. Indeed, exercise-induced changes in TNF-α and IL-8 concentrations are much greater
in the muscle and interstitial cells than the circulation [48,49]. We observed some high CK
responders, based on a lower limit for exertional rhabdomyolysis (CK ≥ 1000 U/L [50])
and yet our changes in muscle function were comparatively moderate. A dissociation
between strength loss and histological evidence of fibre damage (i.e., greater histopathology
relative to the magnitude of strength loss) has been observed previously [41,51,52]. Alterna-
tively, MVC measures may not have been sensitive enough to detect performance changes.
Torque is the product of force and movement arm, the latter being joint angle dependent.
MVC measurements were performed at the same joint angle (90◦), which ensured valid
comparisons within and between individuals, but it may have been better to assess muscle
force output at a longer muscle length or perform measures of dynamic strength, to better
simulate the movement pattern associated with the exercise task. Future studies should
include measures of dynamic and isometric performance. Regretfully, we did not monitor
which phase of the menstrual cycle our female participants were in at the time of testing.
Whilst hormone fluctuations throughout the menstrual cycle may affect EIMD in terms of
strength loss and DOMS, they are unlikely to explain the difference we have observed in
CK [53]. Finally, whilst our supplementation was appropriately timed (ingested within the
critical window of 1–2 h pre-exercise), we acknowledge that anthocyanin intake should be
tailored to individual needs. We provided an absolute rather than relative (mg/kg) dose of
anthocyanins. The daily consumption of 3 g NZBC extract contained 105 mg anthocyanins,
which retrospectively equated to 1.6 ± 0.3 mg/kg. This is believed to be the minimal
effect dose [35] and has been shown to facilitate recovery from exercise-induced oxidative
stress [30,35]. Future studies should manipulate the administered NZBC amount based on
participants body weight and total anthocyanins (mg) in the NZBC extract to ensure all
participants obtain more than the minimal effect dose.
5. Conclusions
In conclusion, this study demonstrates that consuming an anthocyanin-rich black
currant extract 8 days prior to and for 4 days following strenuous eccentric exercise resulted
in faster recovery of muscle function and attenuated muscle soreness and serum CK activity.
Prolonged supplementation with NZBC has been shown by others to facilitate exercise
recovery [36] but the capacity to promote (or mitigate) training-induced adaptations is
unknown. Future research should examine the effect of chronic daily NZBC supplementa-
tion on training capacity (performance on successive days) and the hypertrophic response
to resistance exercise in recreationally active and athletic populations. Muscle biopsies
should be acquired to investigate exercise-induced inflammation and oxidative stress to
examine the mechanisms and confirm the extent of reduced secondary muscle damage and
facilitated recovery associated with daily consumption of NZBC extract.
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